Holocene Advisors
USNA icon

Holocene Advisors’s Usana Health Sciences USNA Stock Holding History

Holocene Advisors’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-4,957
Closed -$508K – 976
2021
Q2 		$508K Buy
4,957
+2,178
+78% +$219K ﹤0.01% 739
2021
Q1 		$271K Sell
2,779
-7,465
-73% -$679K ﹤0.01% 766
2020
Q4 		$790K Buy
10,244
+1,111
+12% +$85.9K 0.01% 583
2020
Q3 		$673K Buy
+9,133
New +$733K 0.01% 541
2020
Q2 		– Sell
-12,836
Closed -$741K – 785
2020
Q1 		$741K Sell
12,836
-4,187
-25% -$291K 0.01% 482
2019
Q4 		$1.34M Sell
17,023
-12,521
-42% -$922K 0.01% 500
2019
Q3 		$2.02M Buy
+29,544
New +$1.98M 0.02% 299
2019
Q1 		– Sell
-2,434
Closed -$287K – 812
2018
Q4 		$287K Buy
+2,434
New +$281K ﹤0.01% 565

Other funds holding USNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Holocene Advisors's USNA Position: Q3 2021 in Review

Holocene Advisors sold out of Usana Health Sciences (USNA) in Q3 2021, closing a stake of 4,957 shares — an estimated $508K sold.

Holocene Advisors first reported a position in USNA in Q4 2018 and held it in 8 quarters. The position peaked at $2.02M in Q3 2019. 180 funds tracked by Wall St. Rank hold USNA as of Q3 2021.

  • Holocene Advisors reported no remaining Usana Health Sciences position as of Q3 2021 after selling out during the quarter.
  • Holocene Advisors sold 4,957 Usana Health Sciences shares in Q3 2021, an estimated $508K.
  • Holocene Advisors first reported a position in Usana Health Sciences in Q4 2018 and held it in 8 quarters.
  • Holocene Advisors's Usana Health Sciences position peaked at $2.02M in Q3 2019.
  • 180 funds tracked by Wall St. Rank held Usana Health Sciences as of Q3 2021.

Based on Holocene Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.